A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

The goal of this protocol is to evaluate changes in metabolic activity and refractive function of the lens in response to experimental treatment.

Abstract

As the leading cause of blindness, cataracts are a significant burden for the tens of millions of people affected globally by this condition. Chemical exposures, among other environmental factors, are an established cause of cataracts. Ocular toxicity testing can assess whether pharmaceuticals and their components may contribute to lens damage that may lead to cataracts or aid the treatment of cataracts.

In vitro studies and in vivo animal testing can be used for assessing the safety of chemicals prior to clinical studies. The Draize test-the current in vivo standard for ocular toxicity and irritancy testing-has been criticized for lack of sensitivity and objective measurements of determining ocular toxicity. In vitro cell-based assays are limited as cell cultures cannot appropriately model an intact functional lens.

The method described here is a sensitive in vitro alternative to animal testing, designed to evaluate the response of the intact bovine lens to treatment at both the cellular activity level and for overall refractive performance. The non-toxic reagent resazurin is metabolized in proportion to the level of cell activity. The lens laser-scanner assay measures the ability of the lens to refract incident beams of light to a single point with minimal error, directly relevant to its natural function. The method may be used to determine both acute and delayed changes in the lens, as well as the recovery of the lens from chemical or environmental exposures.

Introduction

Affecting over 20 million people, cataracts are the most prevalent cause of blindness worldwide1,2. Cataracts are most commonly due to age-related changes in the lens but are also induced from trauma, genetic conditions, disease, or toxic exposures2. Currently, treatment involves surgical intervention to replace the lens, an expensive and invasive procedure accessible mainly to those in developed countries. The extensive burden of cataract has directed decades of research towards cataract prevention and the development of non-surgical treatment. In both cases, the importance of preclinical testing for toxicity, efficacy, and pharmacokinetics of ophthalmic drugs is paramount. This process of drug development relies heavily on the information provided by studies performed in animals.

The current standard for ocular toxicity testing in vivo is the Draize test, involving the delivery of a test compound to the conjunctival sac of a live animal. The test has been significantly criticized, particularly concerning animal ethics, subjectivity, poor repeatability, and variability3. Additionally, there is no component of the Draize test that directly monitors the effects of test substances on the lens. Considerable effort has been invested in developing alternative in vitro models4. However, none have been sufficiently validated to replace the Draize test5. Similarly, many of these models face limitations with respect to the direct application to cataracts and other complex pathologies6. For example, methods grading lens transparency when placed over a grid are inherently subjective7. Cell culture studies are reliable and highly utilized, though cell monolayer characteristics may diverge from primary tissue culture8.

Whole lenses can be dissected from the eyes of animals and cultured to maintain their original structure and function. One assay that is useful for assessing lens function while maintaining the organ's condition is the lens laser-scanner assay involving a scanner developed at the University of Waterloo in Canada. The assay is a scanning system that uses a series of laser projections to measure the optical quality or refractive performance of the lens. Lenses are scanned in their custom two-segment culture chambers, allowing beams to pass from below through the lens (Figure 1A). A camera fixed inside the scanner captures the image of the laser passing through the lens at numerous points. The scanner software computes the distance behind the lens at which it intersects with a central axis (back vertex distance, BVD), producing a series of measurements that indicate how consistently the lens focuses light to a single point (Figure 1).

The cellular properties of the lens, such as the tight and ordered arrangement of its cells, help maintain transparency and minimize scatter so that the lens can functionally focus light9. This measure can be used to interpret how significantly a chemical disrupts the essential structure of the lens, such as the gradient refractive index, and how much function is compromised because of the induced opacities. Other studies that have followed the response of cultured lenses and lens vesicles suggest that light scatter is a product of structural changes, as compared to metabolic changes, and that disruptions to lens lipids and proteins may affect the refractive index and consequently increase scatter10,11.

The lens laser-scanner can be used in conjunction with metabolic reagents in assays to determine biochemical measures of cell toxicity. Resazurin is a non-toxic chemical reagent metabolized by active cells, producing a reduced product (resorufin) with a measurable fluorescence12. The lens is largely devoid of organelles, except the metabolically active mitochondria concentrated within the anterior epithelium and superficial cortical fiber cells, fulfilling lens energy requirements13,14. Damage to the lens at the cellular level may disrupt metabolism and often precedes the onset of pathogenic structural changes and cataract15.

The purpose of this method is to evaluate the effect of xenobiotic and environmental exposures on the lens, which may contribute to cataract development. The protocol involves two assays to evaluate the effect of a treatment using the cultured bovine lens. The advantage of this approach is that it provides both a cellular and functional evaluation of how the lens as a primary tissue responds to treatment. It is a sensitive and objective evaluation of the lens as compared to other common methods16,17,18.

The model has been successfully used to evaluate the effects of various exposures, including surfactants, consumer products, alcohols, and ultraviolet radiation17,19,20. Changes in optical quality are consistently present in cultured lenses as a response to toxic exposure21. The ability of this method to maintain long-term lens culture is well-suited for monitoring the potentially delayed effect of a compound, and the recovery of the lens from induced damage or cataract22,23. Results produced from the application of this protocol can be used to reduce dependence on animal testing in the development of ophthalmic products.

Protocol

All experimental protocols were carried out in compliance with the University of Waterloo ethics policies for research using animal tissue. The bovine eyes for the current study were abattoir-provided, obtained from non-dairy cows within a few hours of death, and were dissected immediately, a process that takes up to 8 h from obtaining the eyes. Eyes should be dissected immediately to preserve sterility and dissection quality. The culture medium is prepared to a pH of 7.4 and sterile-filtered prior to supplementation with FBS21. All procedures are carried out under sterile conditions, with material and equipment sources listed in the Table of Materials.

1. Bovine lens culture

  1. Dissect lenses by removing extraocular muscles and tissue from the sclera, removing the posterior half of the globe and vitreous, removing the iris and ciliary body together with the lens, then cutting away the zonular attachments, with the final cut positioned such that the lens will drop into the medium-filled culture chamber.
  2. Culture the dissected lenses in custom chambers with a base adapted to fit the laser-scanning system, with 21 mL of sterile-filtered medium, at 37 Β°C and 5% CO2. Use 3% fetal bovine serum (FBS)-supplemented culture medium with 1% penicillin-streptomycin, 9.4 g/L M-199, 0.1 g/L L-glutamine, 5.96 g/L HEPES, 2.2 g/L sodium bicarbonate, and 7 mL/L NaOH. Store unused culture medium in the refrigerator for up to 7 days.
  3. Replace the culture medium every 1-2 days. Warm the culture medium for an hour at 37 Β°C prior to use. Use a suction-connected sterile Pasteur pipette to aspirate the medium from an individual culture chamber and replenish immediately with the supplemented medium.
  4. Culture the lenses for 48 h after dissection to allow time for physical damage to manifest. Inspect and scan the lenses for optical quality according to section 4 prior to inclusion in an experiment.
    ​NOTE: Lenses are oriented face-down in preparation for the laser-scanner assay.

2. Control procedure

  1. Prepare a solution with the desired concentration of a solubilizing agent that is compatible with the chemical compound and culture medium.
  2. Prepare a vehicle control solution by adding the solubilizing agent to supplemented medium. Warm the control solution for an hour at 37 Β°C prior to experimentation.
  3. Use a Pasteur pipette connected to suction to aspirate the culture medium from control lens chambers. Replenish the chambers with the control solution. If required, perform this step with samples in triplicate.
    NOTE: A minimum volume of 7 mL is required to completely cover the lens in the anterior face-up position. The conditions for controls in the current study were 21 mL of untreated medium control, 21 mL of a vehicle control medium, and 7 mL of phosphate-buffered saline (PBS).
  4. Culture the lenses in control medium for 2 days, then replace with new control medium according to section 1. For short-term exposures, aspirate the control solution from the chambers and perform a rinse at least three times with unsupplemented culture medium before resuming the lens culture protocol as described in section 1.0.
  5. Allow the lenses to acclimate in the incubator at 37 Β°C and 5% CO2 for at least 3.5 h prior to the assessment of optical quality.

3. Exposure procedure

  1. Prepare a solution with the desired concentration of a solubilizing agent that is compatible with the chemical compound and culture medium. Combine the chemical with the solubilizing agent, allowing the appropriate time for interaction if required.
    NOTE: 2-Hydroxypropyl-Ξ²-cyclodextrin was used in the current study to enhance the solubility of lanosterol (0.033 g/L) in medium. Benzalkonium chloride (BAK 0.0075%) solution was prepared using PBS.
  2. Incorporate the solubilized chemical into the culture medium. Prepare a total volume sufficient to provide 21 mL of medium to all lens samples. Warm the experimental medium for an hour at 37 Β°C prior to experimentation.
  3. Use a Pasteur pipette connected to suction to aspirate the culture medium from the lens chambers. Immediately replenish the chambers with the test solution. After the exposure interval, replace with supplemented culture medium, performing a rinse first if needed. If required, perform this step with samples in triplicate.
    NOTE: In the current study, test conditions were 21 mL of lanosterol-supplemented medium and 7 mL of a BAK 0.0075% solution. A minimum volume of 7 mL is required to completely cover the lens. In this case, lenses must first be oriented anterior face-up. A Pasteur pipette can be used to create a current in the culture chamber with some of the surrounding culture medium to repositions the lens.
  4. Return the lenses to the incubator for at least 3.5 h to acclimate prior to the assessment of optical quality.
    ​NOTE: Lenses are oriented face-down in preparation for the laser-scanner assay.

4. Optical quality assay (lens laser-scanner)

  1. Ensure that the lenses are oriented with the anterior face down and visually level in the culture chamber, using the technique from step 3.3 to adjust the position of the lens if needed.
    NOTE: This position ensures the incident beam will be reflected up through the chamber bottom and pass through the lens from the anterior to the posterior surface.
  2. Position a lens culture chamber into the laser-scanner such that the chamber carriage pin fits into the slot in the chamber base.
  3. Select the lens and scanpoint for which to perform a scan, right-click on scan lens, and wait for the scanner prompts for the beam to be found and aligned. Select well-distanced beginning and endpoints for the beam behind the lens. Ensure the central beam is aligned using the gross and fine adjustment buttons in the scanner software and adjustment knob on the scanner. When the beam is aligned, click calibrate and input an appropriate selection of radial steps and beam separation.
    NOTE: For this study using the bovine lens, the settings for radial steps and beam separation were set to 10 steps and 0.5 mm, respectively. The first scan that the scanner performs serves to calibrate the laser-scanner. This is required once, and all additional lens scans may be performed directly after alignment.
  4. Once the scanner has been calibrated, click scan. Wait for values to be generated for BVD mean, standard deviation, and error along one axis after completion of the lens scan, and the scope of the beam has been set. Set the scope from where beams exit the lens to the desired endpoint, selecting the maximum distance behind the lens while excluding any apparent interference.
  5. Use the generated chart to view the individual back vertex distances for each beam.
    ​NOTE: Exclude beams passing through lens sutures. To exclude a beam, use the on-screen legend to right-click on an individual beam and select exclude.
  6. Manually pivot the position of the culture chamber base inside the scanner by 90Β°, such that the second scan along the anterior lens surface will be perpendicular to the previous scan. Ensure the central beam is aligned as detailed in step 4.3, and then scan the lens.

5. Metabolic activity assay (resazurin)

  1. Prepare medium without FBS. Warm the medium for an hour at 37 Β°C. Prepare 50 mL of 8% resazurin reagent in unsupplemented medium.
    NOTE: It is sufficient to prepare 50 mL to fill all wells in a 12-well plate. The solution should be prepared sterile under dim conditions in an opaque container, as resazurin is light-sensitive.
  2. Add 3.8 mL of 8% resazurin solution to each well within a clear-bottom, sterile 12-well plate to cover the lens.
  3. Use sterile metal scoops to carefully lift lenses from under the posterior surface and perform a rinse using a Pasteur pipette to wash the lens with a small volume of unsupplemented culture medium. Place the lenses individually in each well.
  4. Incubate the well plate at 37 Β°C and 5% CO2 for 5 h. After the incubation, remove the lenses with metal scoops from the wells and place them in an animal waste disposal container. Transfer a 100 Β΅L sample from each well into a sterile, clear-bottom, 96-well plate.
    NOTE: Lenses may be assessed multiple times with the metabolic activity assay. In this case, return the lenses to the culture chambers with fresh medium for incubation. The metabolic activity assay is best performed once all scans are completed, as the dye may affect the BVD measurements.
  5. Measure the endpoint fluorescence of the 100 Β΅L samples using a fluorescent plate reader, with the excitation and emission wavelengths set at 560 nm and 590 nm, respectively.

6. Data analysis

  1. For the optical quality assay, calculate the average of the software-calculated values for BVD error24 from the two scans performed at each time point. Perform this calculation for all lenses and all scanpoints.
  2. For the metabolic activity assay, collect the endpoint relative fluorescence values generated by the plate reader. Normalize the data by setting the average of all control values at a scanpoint to 100%. Calculate the activity of each lens as a percentage of the average control value for that scanpoint.
  3. Perform a normality test for all experiment groups. Assuming the data are normal, analyze the BVD error differences between control and experimental lenses using the two-way ANOVA. Additionally, perform Tukey's post-hoc multiple comparisons test. Perform a one-way ANOVA and Dunnett's post-hoc test for the metabolic activity data.

Results

Figure 2 and Figure 3 (n = 6) demonstrate the results of a study testing the effect of chemical treatment (lanosterol) on the bovine lens. Lanosterol is a naturally occurring sterol in the lens that once showed promising results as a potential pharmaceutical intervention for cataracts25, although this has yet to be proven26. The study design included a medium and vehicle control for the compound. There was no signi...

Discussion

The purpose of this protocol is to directly evaluate the effects of chemicals or environmental exposures on the lens in primary tissue culture. First, lenses are dissected and scanned for optical quality. Prevention of contamination and ensuring dissection quality are critical. Lenses are scanned at periodic intervals to continuously monitor changes in refractive function with respect to the control group or preexposure condition. The metabolic activity assay represents an endpoint to determine whether the exposures have...

Disclosures

The authors have no conflicts of interest to disclose.

Acknowledgements

Thanks to the Natural Sciences and Engineering Research Council (NSERC) and the Canadian Optometric Education Trust Fund (COETF) for the funds for this project.

Materials

NameCompanyCatalog NumberComments
(2-Hydroxypropyl)-Ξ²-cyclodextrinSigma-AldrichH107Powder
1 L bottle-top filtration systemVWR97066-204Full Assembly, bottle-top, 0.2 ΞΌm
100 mm Petri dishVWR89022-320Slippable, media saver style, sterile
12 well-plateCorning353043Sterile, clear-bottom
35 mm petri dishVWR25373-041Falcon disposable petri dishes, sterile, Corning
96 well-plateVWR29442-072Sterile, clear-bottom
Alamar blue (resazurin)Fischer ScientificDAL1100Molecular Probes cell viability reagent
Benzalkonium chloride solutionSigma-Aldrich6324950% in H20
Biosafety cabinet
Cytation 5 plate readerBioTekCYT5MPVCell imaging multi-mode reader
Fetal bovine serumThermoFischer Scientific12484028Qualified, heat inactivated, Canada
HEPESSigma-AldrichH3375For cell culture, powder
Incubator
LanosterolSigma-AldrichL5768β‰₯93%, powder
L-glutamineSigma-AldrichFor cell culture, powder
Medium (M-199)Sigma-AldrichM3769Modified, with Earleβ€²s salts, without L-glutamine, sodium bicarbonate, and phenol red, powder, suitable for cell culture
Pasteur pipettes5 3/4'', with and without cotton
Penicillin-StreptomycinThermoFischer Scientific15140122Liquid (10,000 U/mL)
Phospate buffer saline (PBS)liquid, sterile, suitable for cell culture
Pipette tips (100 Β΅L, 1,000 Β΅L, 5,000 Β΅L)VWRSterile
ScanTox (lens laser-scanner)Specially developed in-houseN/AScans lens with a laser to determine lens optical quality
ScanTox culture chamberSpecially developed in-houseN/AHolds bovine lens in place during testing and culturing
Sodium bicarbonateSigma-AldrichS5761For cell culture, powder
Sodium hydroxideSigma-AldrichS27701.0 N, BioReagent, suitable for cell culture

References

  1. Khairallah, M., et al. Number of people blind or visually impaired by cataract worldwide and in world regions, 1990 to 2010. Investigative Ophthalmology & Visual Science. 56 (11), 6762-6769 (2015).
  2. Priority eye diseases. World Health Organization Available from: https://www.who.int/blindness/causes/priority/en/index1.html (2014)
  3. Wilhelmus, K. R. The Draize eye test. Survey of Ophthalmology. 45 (6), 493-515 (2001).
  4. Jester, J. V. Extent of corneal injury as a biomarker for hazard assessment and the development of alternative models to the Draize rabbit eye test. Cutaneous and Ocular Toxicology. 25 (1), 41-54 (2006).
  5. Vinardell, M. P., Mitjans, M. Alternative methods for eye and skin irritation tests: an overview. Journal of Pharmaceutical Sciences. 97 (1), 46-59 (2008).
  6. Bonneau, N., Baudouin, C., Reaux-Le Goazigo, A., Brignole-Baudouin, F. An overview of current alternative models in the context of ocular surface toxicity. Journal of Applied Toxicology. , (2021).
  7. Bree, M., Borchman, D. The optical properties of rat, porcine and human lenses in organ culture treated with dexamethasone. Experimental Eye Research. 170, 67-75 (2018).
  8. Leist, C. H., Meyer, H. P., Fiechter, A. Potential and problems of animal cells in suspension culture. Journal of Biotechnology. 15 (1-2), 1-46 (1990).
  9. Bassnett, S., Shi, Y., Vrensen, G. F. Biological glass: structural determinants of eye lens transparency. Philosophical Transactions of the Royal Society of London. Series B, Biological sciences. 366 (1568), 1250-1264 (2011).
  10. Alghamdi, A. H. S., Mohamed, H., Sledge, S. M., Borchman, D. Absorbance and light scattering of lenses organ cultured with glucose. Current Eye Research. 43 (10), 1233-1238 (2018).
  11. Tang, D., et al. Light scattering of human lens vesicles in vitro. Experimental Eye Research. 76 (5), 605-612 (2003).
  12. O'Brien, J., Wilson, I., Orton, T., Pognan, F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. European Journal of Biochemistry. 267 (17), 5421-5426 (2000).
  13. Bantseev, V., Sivak, J. G. Confocal laser scanning microscopy imaging of dynamic TMRE movement in the mitochondria of epithelial and superficial cortical fiber cells of bovine lenses. Molecular Vision. 11, 518-523 (2005).
  14. Remington, L. A., McGill, E. C. . Clinical Anatomy of the Visual system. , (1998).
  15. Michael, R. Development and repair of cataract induced by ultraviolet radiation. Ophthalmic Research. 32, 1-44 (2000).
  16. Hamid, R., Rotshteyn, Y., Rabadi, L., Parikh, R., Bullock, P. Comparison of alamar blue and MTT assays for high through-put screening. Toxicology In Vitro. 18 (5), 703-710 (2004).
  17. Bantseev, V., et al. Mechanisms of ocular toxicity using the in vitro bovine lens and sodium dodecyl sulfate as a chemical model. Toxicological Sciences. 73 (1), 98-107 (2003).
  18. Sivak, J. G., Herbert, K. L., Segal, L. Ocular lens organ culture as a measure of ocular irritancy: The effect of surfactants. Toxicology Methods. 4 (1), 56-65 (1994).
  19. Youn, H. Y., Moran, K. L., Oriowo, O. M., Bols, N. C., Sivak, J. G. Surfactant and UV-B-induced damage of the cultured bovine lens. Toxicology In Vitro. 18 (6), 841-852 (2004).
  20. Sivak, J. G., Stuart, D. D., Herbert, K. L., Van Oostrom, J. A., Segal, L. Optical properties of the cultured bovine ocular lens as an in vitro alternative to the Draize eye toxicity test: Preliminary validation for alcohols. Toxicology Methods. 2 (4), 280-294 (1992).
  21. Wong, W., Sivak, J. G., Moran, K. L. Optical response of the cultured bovine lens; testing opaque or partially transparent semi-solid/solid common consumer hygiene products. Toxicology In Vitro. 17 (5-6), 785-790 (2003).
  22. Sivak, J. G., Stuart, D. D., Weerheim, J. A. Optical performance of the bovine lens before and after cold cataract. Applied Optics. 31 (19), 3616-3620 (1992).
  23. Stuart, D. D., Sivak, J. G., Cullen, A. P., Weerheim, J. A., Monteith, C. A. UV-B radiation and the optical properties of cultured bovine lenses. Current Eye Research. 10 (2), 177-184 (1991).
  24. Dovrat, A., Sivak, J. G. Long-term lens organ culture system with a method for monitoring lens optical quality. Photochemistry and Photobiology. 81 (3), 502-505 (2005).
  25. Zhao, L., et al. Lanosterol reverses protein aggregation in cataracts. Nature. 523 (7562), 607-611 (2015).
  26. Daszynski, D. M., et al. Failure of oxysterols such as lanosterol to restore lens clarity from cataracts. Scientific Reports. 9 (1), 8459 (2019).
  27. Baudouin, C., Denoyer, A., Desbenoit, N., Hamm, G., Grise, A. In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis). Transactions of the American Ophthalmological Society. 110, 40-63 (2012).
  28. Schartau, J. M., Kroger, R. H., Sjogreen, B. Short-term culturing of teleost crystalline lenses combined with high-resolution optical measurements. Cytotechnology. 62 (2), 167-174 (2010).
  29. Truscott, R. J. Age-related nuclear cataract-oxidation is the key. Experimental Eye Research. 80 (5), 709-725 (2005).
  30. Deeley, J. M., et al. Human lens lipids differ markedly from those of commonly used experimental animals. Biochimica et Biophysica Acta. 1781 (6-7), 288-298 (2008).
  31. Bantseev, V., et al. Effect of hyperbaric oxygen on guinea pig lens optical quality and on the refractive state of the eye. Experimental Eye Research. 78 (5), 925-931 (2004).
  32. Choh, V., Sivak, J. G. Lenticular accommodation in relation to ametropia: the chick model. Journal of Vision. 5 (3), 165-176 (2005).
  33. Oriowo, O. M., et al. Evaluation of a porcine lens and fluorescence assay approach for in vitro ocular toxicological investigations. Alternatives to Laboratory Animals: ATLA. 30 (5), 505-513 (2002).
  34. van Doorn, K. L., Sivak, J. G., Vijayan, M. M. Optical quality changes of the ocular lens during induced parr-to-smolt metamorphosis in Rainbow Trout (Oncorhynchus mykiss). Ocular lens optical quality during induced salmonid metamorphosis. Journal of Comparative Physiology. A, Neuroethology, Sensory, Neural, and Behavioral Physiology. 191 (7), 649-657 (2005).
  35. Herbert, K. L., Sivak, J. G., Bell, R. C. Effect of diabetes and fructose/non-fructose diet on the optical quality (cataracts) of the rat lens. Current Eye Research. 19 (4), 305-312 (1999).
  36. Wormstone, I. M., Collison, D. J., Hansom, S. P., Duncan, G. A focus on the human lens in vitro. Environmental Toxicology and Pharmacology. 21 (2), 215-221 (2006).
  37. Oyster, C. W. The human eye: structure and function. Sinauer Associates. , (1999).
  38. Xu, M., McCanna, D. J., Sivak, J. G. Use of the viability reagent PrestoBlue in comparison with alamarBlue and MTT to assess the viability of human corneal epithelial cells. Journal of Pharmacological and Toxicological Methods. 71, 1-7 (2015).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Organ Culture SystemToxicity AssessmentIntraocular TreatmentPharmaceuticalsExcipientsCataractsOcular ToxicityIn Vitro TestingDraize TestBovine LensResazurinLens Laser scanner AssayCell ActivityRefractive Performance

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright Β© 2025 MyJoVE Corporation. All rights reserved